Live tape
Top 8, mentions 7d6,218NVDA1,025 mentions▲ +0.09NKE1,003 mentions+0.01GOOGL967 mentions▲ +0.04LULU955 mentions▲ +0.03TSLA861 mentions▲ +0.06META489 mentions▲ +0.04MSFT461 mentions▲ +0.07QQQ457 mentions▲ +0.08

Equity · Healthcare

CON

Concentra Group Holdings Parent, Inc. · NYSE

$32 +1.27% 1D Finazon · prior-day close · Jul 27, 2026
Price · Chart
Our own end-of-day closes 31 sessions
$34 $26 11 Jun 27 Jul

The line runs $27 on 11 June through $32 on 27 July, on a scale from $26 to $34. Days the market did not trade hold the previous close, flat.

The chart above plots the price of CON over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 31 sessions over that window: $27 on 11 June 2026 through $32 on 27 July 2026.

Market cap $4.1B
P/E (TTM) 19.6
52-week range $18.69 – $32
Avg volume 265.4K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 8, 2026

CON insider trades

SEC Form 4 · last 90 days · newest reported trade 3 Aug 2026
Open-market buys 0
Open-market sells 2
Net sold $8.10M
Non-trade filings 1
Date Insider Type Shares Value
03 Aug 2026 ORTENZIO ROBERT A Director Sell 130,000 $4.14M
01 Jul 2026 ORTENZIO ROBERT A Director Sell 130,000 $3.96M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
21 Aug 2026 ORTENZIO ROBERT A Director Other 1,940,000 $67.22M

CON reported financials

SEC EDGAR XBRL

CON reported revenue of $2.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $166.4M.

Figure Reported Period
Revenue $2.2B 31 Dec 2025 fiscal year
Net income $166.4M 31 Dec 2025 fiscal year
Diluted EPS $1.30 31 Dec 2025 fiscal year
Total assets $3.0B 30 Jun 2026 at period end
Total equity $477.1M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CON earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.51 $606M
31 Mar 2026 Q1 2026 $0.39 $570M
31 Dec 2025 FY 2025 $1.30 $2.16B
30 Sep 2025 Q3 2025 $0.38 $573M
30 Jun 2025 Q2 2025 $0.35 $551M
31 Mar 2025 Q1 2025 $0.30 $501M
31 Dec 2024 FY 2024 $1.46 $1.90B
30 Sep 2024 Q3 2024 $0.37 $490M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CON institutional holders

SEC Form 13F

6 of the 45 institutional funds we track reported a CON position for the quarter ended 30 Jun 2026 — a combined $38.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Added +215.2% shares 750,048 $22.3M
D. E. Shaw & Co. Held (±25%) +7.4% shares 154,333 $4.6M
Citadel Advisors Trimmed −87.7% shares 151,032 $4.5M
Point72 Asset Management New position 103,773 $3.1M
AQR Capital Management Added +69.2% shares 78,958 $2.3M
GAMCO Investors Added +40.7% shares 41,170 $1.2M

Source: SEC EDGAR 13F filings

CON fails-to-deliver

SEC CNS data

On 07 Aug 2026, 1 shares of CON failed to deliver (about $31).

Settlement date Shares failed Notional % of shares out
07 Aug 2026 1 $31 <0.001%
05 Aug 2026 92,236 $2.9M 0.072%
04 Aug 2026 92,222 $2.9M 0.072%
29 Jul 2026 48 $2K <0.001%

Source: SEC fails-to-deliver (CNS) data